Published in World J Gastroenterol on July 07, 2010
Molecular identification and targeting of colorectal cancer stem cells. Oncotarget (2010) 1.33
CD133: a cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol (2013) 1.15
CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma. World J Urol (2011) 0.83
Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro. Cancers (Basel) (2011) 0.81
Intra-tumor heterogeneity from a cancer stem cell perspective. Mol Cancer (2017) 0.80
CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy. BMC Cancer (2013) 0.79
The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers. J Ovarian Res (2012) 0.75
Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article. Medicine (Baltimore) (2016) 0.75
Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies. Mol Cancer (2017) 0.75
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
The history of cancer epigenetics. Nat Rev Cancer (2004) 14.38
DNA methylation and human disease. Nat Rev Genet (2005) 12.00
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
Cancer stem cells: models and concepts. Annu Rev Med (2007) 8.06
DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol (2005) 5.02
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A (2008) 4.60
Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A (2005) 4.59
The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem (2000) 3.33
AC133/CD133/Prominin-1. Int J Biochem Cell Biol (2005) 2.80
Cancer stem cells--old concepts, new insights. Cell Death Differ (2008) 2.56
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene (2008) 2.47
Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells (2006) 1.80
Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood (2003) 1.78
Characteristics of cell lines established from human colorectal carcinoma. Cancer Res (1987) 1.69
Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62
Genome-wide profiling of promoter methylation in human. Oncogene (2006) 1.55
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res (2008) 1.51
Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res (2008) 1.27
Stem cells and cancer: an intimate relationship. J Pathol (2006) 1.25
Pluripotency associated genes are reactivated by chromatin-modifying agents in neurosphere cells. Stem Cells (2008) 1.24
Comparative genomics on PROM1 gene encoding stem cell marker CD133. Int J Mol Med (2007) 1.13
Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis. Bioessays (2007) 0.94
Methylation of the prominin 1 TATA-less main promoters and tissue specificity of their transcript content. Biochim Biophys Acta (2008) 0.94
Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer. Anticancer Res (2009) 0.85
Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat (2005) 11.27
The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res (2009) 7.87
Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. Science (2008) 5.14
Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science (2011) 3.77
Prolongation of the period between biopsy and EMR can influence the nonlifting sign in endoscopically resectable colorectal cancers. Gastrointest Endosc (2008) 3.05
2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat (2004) 2.90
Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in Drosophila. Cell (2013) 2.36
Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Ann Hematol (2011) 2.28
Coordination of multiple dual oxidase-regulatory pathways in responses to commensal and infectious microbes in drosophila gut. Nat Immunol (2009) 2.06
A Spätzle-processing enzyme required for toll signaling activation in Drosophila innate immunity. Dev Cell (2006) 1.93
Regulation of DUOX by the Galphaq-phospholipase Cbeta-Ca2+ pathway in Drosophila gut immunity. Dev Cell (2009) 1.87
Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.63
Deterioration of myocardial function in paradoxical low-flow severe aortic stenosis: two-dimensional strain analysis. J Am Soc Echocardiogr (2011) 1.57
Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects. J Oral Pathol Med (2010) 1.55
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.53
Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg (2008) 1.51
Feasibility of laparoscopic techniques as the surgical approach of choice for primary colorectal cancer: an analysis of 570 consecutive cases. Surg Endosc (2008) 1.48
Neonatal hair nicotine levels and fetal exposure to paternal smoking at home. Am J Epidemiol (2008) 1.48
Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol (2006) 1.44
Comparison of plain balloon and cutting balloon angioplasty for the treatment of restenosis with drug-eluting stents vs bare metal stents. Circ J (2010) 1.42
Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev (2005) 1.41
Mesenchymal neoplasms of the major salivary glands: clinicopathological features of 18 cases. Eur Arch Otorhinolaryngol (2007) 1.41
Basal cell adenocarcinoma of the salivary gland: a morphological and immunohistochemical comparison with basal cell adenoma with and without capsular invasion. Diagn Pathol (2013) 1.39
Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer. J Thorac Oncol (2013) 1.39
Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res (2004) 1.37
Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J Gastroenterol (1999) 1.34
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 1.33
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol (2003) 1.33
Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg (2012) 1.31
Metastatic carcinomas to the oral cavity and oropharynx. Korean J Pathol (2012) 1.27
Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene (2004) 1.24
Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol (2007) 1.23
Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Colorectal Dis (2007) 1.23
Phylogenetic characterization of two novel commensal bacteria involved with innate immune homeostasis in Drosophila melanogaster. Appl Environ Microbiol (2008) 1.22
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet (2003) 1.21
Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res (2005) 1.20
EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer (2011) 1.19
The homeobox gene Caudal regulates constitutive local expression of antimicrobial peptide genes in Drosophila epithelia. Mol Cell Biol (2004) 1.15
A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology (2004) 1.15
Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol (2008) 1.15
Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol (2012) 1.14
Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum (2007) 1.13
Biology of SNU cell lines. Cancer Res Treat (2005) 1.11
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol (2007) 1.11
Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg (2010) 1.10
Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest (2012) 1.10
Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. PLoS One (2013) 1.10
Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer. Cancer Chemother Pharmacol (2011) 1.09
Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines. Int J Cancer (2004) 1.08
Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.07
Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem (2006) 1.06
Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer (2008) 1.06
Prevalence of otolaryngologic diseases in South Korea: data from the Korea national health and nutrition examination survey 2008. Clin Exp Otorhinolaryngol (2010) 1.06
Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling. BMC Cancer (2010) 1.05
Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers. Int J Cancer (2007) 1.04
Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann Surg Oncol (2011) 1.03
Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis (2009) 1.03
Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med (2007) 1.01
A sensitive enzyme immunoassay for measuring cotinine in passive smokers. Clin Chim Acta (2010) 1.01
Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. Head Neck (2011) 1.01
Secondary rhinoplasty of the Asian nose: correction of the contracted nose. Aesthetic Plast Surg (2004) 1.00
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. J Nucl Med (2013) 1.00
Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer. Int J Cancer (2008) 1.00
A cadaveric analysis of the ideal costal cartilage graft for Asian rhinoplasty. Plast Reconstr Surg (2004) 0.99
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma. FASEB J (2013) 0.99
Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer (2004) 0.99
Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med (2007) 0.98
Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res (2005) 0.98
The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis (2004) 0.98
High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid (2007) 0.98
Microsatellite instability testing in Korean patients with colorectal cancer. Fam Cancer (2012) 0.97
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer. Int J Cancer (2012) 0.97
Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis (2004) 0.96
Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys (2005) 0.96
Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation. Cancer Lett (2006) 0.96
18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. Oral Oncol (2007) 0.96
KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX. Ann Surg Oncol (2014) 0.96
Delayed diagnosis of traumatic ventricular septal defect in penetrating chest injury: small evidence on echocardiography makes big difference. J Cardiovasc Ultrasound (2010) 0.96
Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers. Carcinogenesis (2010) 0.96
Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Hum Pathol (2005) 0.96
Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep (2007) 0.95
A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis (2004) 0.95
Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer (2006) 0.95
Myofilament Ca2+ desensitization mediates positive lusitropic effect of neuronal nitric oxide synthase in left ventricular myocytes from murine hypertensive heart. J Mol Cell Cardiol (2013) 0.95
DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun (2004) 0.94
2001 annual report of the Korea Central Cancer Registry: based on registered data from 134 hospitals. Cancer Res Treat (2004) 0.94